Month: December 2019

News

mRNA Day: TriLink, Maravai Look to RNA, Oligonucleotides, and San Diego for Growth | GEN – Genetic Engineering and Biotechnology News

December 23, 2019 Mary Canady Comments Off on mRNA Day: TriLink, Maravai Look to RNA, Oligonucleotides, and San Diego for Growth | GEN – Genetic Engineering and Biotechnology News

href=”https://www.genengnews.com/topics/omics/mrna-day-trilink-maravai-look-to-rna-oligonucleotides-and-san-diego-for-growth/”> A San Diego manufacturer of highly-modified nucleic acids and its parent company have concluded that development of RNA- and oligonucleotide-based therapeutics?as well as the region?s biopharma cluster?will both grow strongly enough in the near […]

No Picture
Events

Crown Bioscience Lunch and Learn: Patient-Derived Experimental Models for Translational Cancer Research : Dec 11, 2019

December 9, 2019 sandiegobiotech Comments Off on Crown Bioscience Lunch and Learn: Patient-Derived Experimental Models for Translational Cancer Research : Dec 11, 2019

Join our interactive Lunch and Learn Seminar in San Diego this December. Register now to explore the latest developments in patient-derived and PDX-derived organoids for oncology drug discovery.Why Attend?New advanced models are needed to improve precl… […]

No Picture
News

Cortexyme Announces Presentation of Data Revealing Link Between Bacterial Pathogen and Genetic Risk for Alzheimer?s Disease

December 7, 2019 sandiegobiotech Comments Off on Cortexyme Announces Presentation of Data Revealing Link Between Bacterial Pathogen and Genetic Risk for Alzheimer?s Disease

SAN DIEGO & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc. (Nasdaq: CRTX) today announced the presentation of new data supporting the on-target activity of COR388, its lead investigational medicine, and linking the ?gingipain hypothe… […]

No Picture
News

Clinical study finds eating within a 10-hour window may help stave off diabetes, heart disease

December 5, 2019 sandiegobiotech Comments Off on Clinical study finds eating within a 10-hour window may help stave off diabetes, heart disease

LA JOLLA?Metabolic syndrome affects nearly 30 percent of the U.S. population, and increases the risk for type 2 diabetes, heart disease and stroke. But lifestyle interventions such as adopting a healthy diet and increasing physical exercise are difficu… […]

No Picture
News

Daphne Koller’s AI startup ends wide search for a data chief, tapping Stanford’s Serafim Batzoglou for the job

December 5, 2019 sandiegobiotech Comments Off on Daphne Koller’s AI startup ends wide search for a data chief, tapping Stanford’s Serafim Batzoglou for the job

A few months back, Illumina VP Serafim Batzoglou got an invite from the woman who had first hired him at Stanford two decades prior: Daphne Koller.
Koller had been searching for months for a chief data officer for her new artificial intelligence biotec… […]

No Picture
News

CB Therapeutics Achieves Major Breakthrough in the Biosynthesis of Psilocybin, Psilocin and Related Tryptamine-based Compounds

December 4, 2019 sandiegobiotech Comments Off on CB Therapeutics Achieves Major Breakthrough in the Biosynthesis of Psilocybin, Psilocin and Related Tryptamine-based Compounds

SAN DIEGO–(BUSINESS WIRE)– #Biosynthesis–CB Therapeutics achieved the successful biosynthesis of psilocybin, psilocin and related tryptamine-based compounds and filed a patent on the process. […]

No Picture
News

Alkahest to Present New Data from Phase 2a Study in Mild-to-Moderate Alzheimer?s Disease at the Clinical Trials in Alzheimer?s Disease (CTAD) Conference

December 3, 2019 sandiegobiotech Comments Off on Alkahest to Present New Data from Phase 2a Study in Mild-to-Moderate Alzheimer?s Disease at the Clinical Trials in Alzheimer?s Disease (CTAD) Conference

SAN CARLOS, Calif., Dec. 02, 2019 (GLOBE NEWSWIRE) — Alkahest Inc., a clinical stage biotechnology company focused on discovering and developing transformative therapies to treat age-related diseases, today announced an oral presentation of data fro… […]